Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 4,286 | 3,218 | 3,565 | 3,316 | 2,660 |
| Gross Profit | 4,286 | 3,218 | 3,565 | 3,316 | 2,660 |
| Operating Expenses | 26,861 | 30,384 | 20,237 | 15,596 | 15,110 |
| Operating Income | -22,575 | -27,166 | -16,672 | -12,280 | -12,450 |
| Interest Expense | 0 | 0 | -446 | 0 | 0 |
| Other Income | 1,034 | 326 | -23 | 328 | 142 |
| Pre-tax Income | -21,541 | -26,840 | -16,249 | -11,952 | -12,308 |
| Income Tax | -6 | -34 | N/A | -8,945 | -36 |
| Net Income Continuous | -21,535 | -26,806 | -16,249 | -3,008 | -12,272 |
| Net Income | $-21,535 | $-26,806 | $-16,249 | $-3,008 | $-12,272 |
| EPS Basic Total Ops | -10.44 | -15.61 | -9.60 | -1.32 | -8.52 |
| EPS Basic Continuous Ops | -10.39 | -15.67 | -9.64 | -1.37 | -8.48 |
| EPS Diluted Total Ops | -10.44 | -15.61 | -9.60 | -1.32 | -8.52 |
| EPS Diluted Continuous Ops | -10.39 | -15.67 | -9.64 | -1.37 | -8.48 |
| EBITDA(a) | $-22,182 | $-27,022 | $-16,504 | $-12,763 | $-11,831 |